Company Filing History:
Years Active: 2013
Title: Béatrice Poirier-Beaudoin: Innovator in HIV Research
Introduction
Béatrice Poirier-Beaudoin is a notable inventor based in Beynes, France. He has made significant contributions to the field of HIV research, particularly in the modulation of immune responses to the virus. His work focuses on innovative therapeutic approaches to combat HIV infection.
Latest Patents
Béatrice Poirier-Beaudoin holds a patent titled "Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence." This patent involves compositions and methods for modulating HIV infection through substances that inhibit the interaction of high mobility box 1 (HMGB1) protein with natural killer (NK) cells. The therapeutic compositions include antibodies and drugs, such as glycyrrhizin, that bind to HMGB1. Additionally, the patent outlines methods for detecting or monitoring HIV infection by quantifying HMGB1 or specific antibodies in biological samples. He has 1 patent to his name.
Career Highlights
Béatrice Poirier-Beaudoin is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work is pivotal in understanding the mechanisms of HIV infection and developing potential therapeutic strategies.
Collaborations
He collaborates with esteemed colleagues, including Marie-Lise Gougeon and Héla Saidi, to advance research in the field of HIV.
Conclusion
Béatrice Poirier-Beaudoin's innovative work in HIV research exemplifies the importance of scientific inquiry in addressing global health challenges. His contributions continue to pave the way for new therapeutic approaches to combat HIV infection.